From Discovery to Decision: Building a Fit-for-Purpose Proteomics Strategy for Clinical Development
Late-stage clinical trial attrition remains one of the most expensive challenges in drug development, with more than half of Phase III programs failing to meet…
Good Manufacturing Practice ligand binding and potency assays are essential for ensuring the quality, safety, and regulatory compliance of biopharmaceutical…
